Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE Guidance - May 2016

The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of May 2016. This month there are three clinical guidelines and two technology appraisals that impact upon primary care.

The Dementia clinical guideline covers preventing, diagnosing, assessing and managing dementia in health and social care. The recommendation on prescribing medicines for Alzheimer’s disease was reviewed and partially updated.

The Crohn's Disease clinical guideline covers the management of Crohn’s disease in children, young people and adults. In this update a new recommendation on inducing remission was added.

The Psychosis and schizophrenia in children and young people clinical guideline covers recognising and managing psychosis and schizophrenia in children and young people. In this update a new recommendation was added on providing information about olanzapine when choosing antipsychotic medication for children and young people with a first episode of psychosis.

The Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease technology appraisal has been updated to include references to the Dementia clinical guideline.

The Canagliflozin, dapagliflozin and empagliflozin technology appraisal recommends these drugs as monotherapy treatment as an option for treating type 2 diabetes in adults for whom metformin is contraindicated or not tolerated and when diet and exercise alone do not provide adequate glycaemic control, only if:

  • a dipeptidyl peptidase‑4 (DPP‑4) inhibitor would otherwise be prescribed and
  • a sulfonylurea or pioglitazone is not appropriate

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'NICE Guidance - May 2016' on Email Share 'NICE Guidance - May 2016' on Delicious Share 'NICE Guidance - May 2016' on Digg Share 'NICE Guidance - May 2016' on Facebook Share 'NICE Guidance - May 2016' on Google+ Share 'NICE Guidance - May 2016' on reddit Share 'NICE Guidance - May 2016' on StumbleUpon Share 'NICE Guidance - May 2016' on Twitter

atomic-wealth

No Comments to “NICE Guidance - May 2016”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,211 spam comments.

atomic-wealth
fond-illness
summer